1. Home
  2. Labeler Index
  3. Nutritional Specialties, Inc.
  4. NDC Product Code: 83027-0050 Virex

NDC 83027-0050 Virex

Asclepias Tuberosa,Echinacea Purpurea,Trifolium Pratense,Natrum Muriaticum,Phytolacca - View Dosage, Usage, Ingredients, Routes, UNII

Table of Contents

  1. Product Information
  2. Product Packages
  3. What is NDC 83027-0050?
  4. Virex Uses
  5. Active Ingredients
  6. Active Ingredients UNII Codes
  7. Inactive Ingredients UNII Codes
  8. Pharmacologic Classes

Product Information

Get all the details for National Drug Code (NDC) 83027-0050 in one place. This page breaks down everything you need to know about the NDC, including proprietary name, active and inactive substances, package configurations, billing units, labeler information, and routes of administration. It also includes enhanced data such as HCPCS codes, FDA product labels with images, UNIIs, and RxNorm cross-references. Whether you're a healthcare professional verifying drug data or a consumer researching medication, this NDC page helps you make informed, accurate decisions.

NDC Product Code:
83027-0050
Proprietary Name:
Virex
Non-Proprietary Name: [1]
Asclepias Tuberosa, Echinacea Purpurea, Trifolium Pratense, Natrum Muriaticum, Phytolacca Decandra, Euphrasia Officinalis, Lac Vaccinum (nspc), Thuja Occidentalis, Calcarea Arsenicica, Camphora, Influenzinum, Cytomegalovirus Nosode, Morbillinum, Variolinum, Coxsackie A2 Nosode, Coxsackie A3 Nosode, Coxsackie A4 Nosode, Coxsackie A7 Nosode, Coxsackie B1 Nosode, Coxsackie B3 Nosode, Coxsackie B5 Nosode, Coxsackie A5 Nosode, Adenoviren Nosode, Epstein Barr Virus Nosode, Coxsackie B4 Nosode
Substance Name: [2]
Asclepias Tuberosa Root; Calcium Arsenate; Camphor (natural); Cow Milk; Echinacea Purpurea Whole; Euphrasia Stricta; Human Adenovirus E Serotype 4 Strain Cl-68578 Antigen; Human Coxsackievirus A; Human Coxsackievirus A2; Human Coxsackievirus A7; Human Coxsackievirus B; Human Coxsackievirus B1; Human Coxsackievirus B3; Human Coxsackievirus B5; Human Herpesvirus 4; Human Herpesvirus 5; Influenza A Virus A/darwin/9/2021 Ivr-228 (h3n2) Antigen (uv, Formaldehyde Inactivated); Influenza A Virus A/victoria/2570/2019 Ivr-215 (h1n1) Antigen (uv, Formaldehyde Inactivated); Influenza B Virus B/austria/1359417/2021 Bvr-26 Antigen (uv, Formaldehyde Inactivated); Influenza B Virus B/phuket/3073/2013 Antigen (uv, Formaldehyde Inactivated); Measles Virus; Phytolacca Americana Root; Sodium Chloride; Thuja Occidentalis Leafy Twig; Trifolium Pratense Flower; Variola Virus
NDC Directory Status:
Human Otc Drug
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Dosage Form:
Spray - A liquid minutely divided as by a jet of air or steam.
Administration Route(s): [4]
Oral - Administration to or by way of the mouth.
Labeler Name: [5]
Nutritional Specialties, Inc.
Labeler Code:
83027
Product Label ID:
a37728d6-2428-42f7-b331-c07cdc4e9956
Marketing Category: [8]
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date: [9]
04-13-2023
End Marketing Date: [10]
01-05-2029
Exclude Flag: [12]
N
Code Navigator:

Code Structure Chart

Product Details

What is NDC 83027-0050?

The NDC code 83027-0050 is assigned by the FDA to the product Virex which is a human over the counter drug product labeled by Nutritional Specialties, Inc.. The generic name of Virex is asclepias tuberosa, echinacea purpurea, trifolium pratense, natrum muriaticum, phytolacca decandra, euphrasia officinalis, lac vaccinum (nspc), thuja occidentalis, calcarea arsenicica, camphora, influenzinum, cytomegalovirus nosode, morbillinum, variolinum, coxsackie a2 nosode, coxsackie a3 nosode, coxsackie a4 nosode, coxsackie a7 nosode, coxsackie b1 nosode, coxsackie b3 nosode, coxsackie b5 nosode, coxsackie a5 nosode, adenoviren nosode, epstein barr virus nosode, coxsackie b4 nosode. The product's dosage form is spray and is administered via oral form. The product is distributed in a single package with assigned NDC code 83027-0050-1 60 ml in 1 bottle, spray . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

What are the uses for Virex?

Adults: 2 to 3 sprays orally, three times daily. Children under twelve one half adult dosage. Do not take within 15 minutes of consuming food, beverage or brushing teeth. Consult a physician for use in children under 12 years of age.

What are Virex Active Ingredients?

An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

Which are Virex UNII Codes?

The UNII codes for the active ingredients in this product are:

  • ASCLEPIAS TUBEROSA ROOT (UNII: 1ZL82U5D18)
  • ASCLEPIAS TUBEROSA ROOT (UNII: 1ZL82U5D18) (Active Moiety)
  • ECHINACEA PURPUREA WHOLE (UNII: QI7G114Y98)
  • ECHINACEA PURPUREA (UNII: QI7G114Y98) (Active Moiety)
  • TRIFOLIUM PRATENSE FLOWER (UNII: 4JS0838828)
  • TRIFOLIUM PRATENSE FLOWER (UNII: 4JS0838828) (Active Moiety)
  • SODIUM CHLORIDE (UNII: 451W47IQ8X)
  • CHLORIDE ION (UNII: Q32ZN48698) (Active Moiety)
  • PHYTOLACCA AMERICANA ROOT (UNII: 11E6VI8VEG)
  • PHYTOLACCA AMERICANA ROOT (UNII: 11E6VI8VEG) (Active Moiety)
  • EUPHRASIA STRICTA (UNII: C9642I91WL)
  • EUPHRASIA STRICTA (UNII: C9642I91WL) (Active Moiety)
  • COW MILK (UNII: 917J3173FT)
  • COW MILK (UNII: 917J3173FT) (Active Moiety)
  • THUJA OCCIDENTALIS LEAFY TWIG (UNII: 1NT28V9397)
  • THUJA OCCIDENTALIS LEAFY TWIG (UNII: 1NT28V9397) (Active Moiety)
  • CALCIUM ARSENATE (UNII: 95OX15I8ZU)
  • ARSENATE ION (UNII: G1DBI405OK) (Active Moiety)
  • CAMPHOR (NATURAL) (UNII: N20HL7Q941)
  • CAMPHOR (NATURAL) (UNII: N20HL7Q941) (Active Moiety)
  • INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED) (UNII: 34C49NV47P)
  • INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED) (UNII: NGL844Y7X6) (Active Moiety)
  • INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED) (UNII: P483J7GX6D)
  • INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED) (UNII: GRN94TP8YV) (Active Moiety)
  • INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED) (UNII: TBV2PPG6EF)
  • INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED) (UNII: 28EAH8253X) (Active Moiety)
  • INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED) (UNII: H2198F8ZNA)
  • INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED) (UNII: 3VSF1BF3SR) (Active Moiety)
  • HUMAN HERPESVIRUS 5 (UNII: 7COI029E6K)
  • HUMAN HERPESVIRUS 5 (UNII: 7COI029E6K) (Active Moiety)
  • MEASLES VIRUS (UNII: HT3R7C012Q)
  • MEASLES VIRUS (UNII: HT3R7C012Q) (Active Moiety)
  • VARIOLA VIRUS (UNII: 7J6DBS5FRN)
  • VARIOLA VIRUS (UNII: 7J6DBS5FRN) (Active Moiety)
  • HUMAN COXSACKIEVIRUS A2 (UNII: 82KK5J435E)
  • HUMAN COXSACKIEVIRUS A2 (UNII: 82KK5J435E) (Active Moiety)
  • HUMAN COXSACKIEVIRUS A (UNII: 6F61V9UVRC)
  • HUMAN COXSACKIEVIRUS A (UNII: 6F61V9UVRC) (Active Moiety)
  • HUMAN COXSACKIEVIRUS A7 (UNII: P3026TK92O)
  • HUMAN COXSACKIEVIRUS A7 (UNII: P3026TK92O) (Active Moiety)
  • HUMAN COXSACKIEVIRUS B1 (UNII: ADL68M27WD)
  • HUMAN COXSACKIEVIRUS B1 (UNII: ADL68M27WD) (Active Moiety)
  • HUMAN COXSACKIEVIRUS B3 (UNII: 69O1DAO10G)
  • HUMAN COXSACKIEVIRUS B3 (UNII: 69O1DAO10G) (Active Moiety)
  • HUMAN COXSACKIEVIRUS B5 (UNII: 63E6RXM429)
  • HUMAN COXSACKIEVIRUS B5 (UNII: 63E6RXM429) (Active Moiety)
  • HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN (UNII: FKD3DUK39I)
  • HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 (UNII: FKD3DUK39I) (Active Moiety)
  • HUMAN HERPESVIRUS 4 (UNII: 2A26YW7PNX)
  • HUMAN HERPESVIRUS 4 (UNII: 2A26YW7PNX) (Active Moiety)
  • HUMAN COXSACKIEVIRUS B (UNII: NCM5G1A67U)
  • HUMAN COXSACKIEVIRUS B (UNII: NCM5G1A67U) (Active Moiety)

Which are Virex Inactive Ingredients UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

Which are the Pharmacologic Classes for Virex?

A pharmacologic class is a group of drugs that share the same scientifically documented properties. The following is a list of the reported pharmacologic class(es) corresponding to the active ingredients of this product.

* Please review the disclaimer below.

Product Footnotes

[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.

[2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

[4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.

[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

[10] What is the End Marketing Date? - This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.

[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions, or because the listing certification is expired, or because the listing data was inactivated by FDA, or because it was discontinued by the labeler. Possible values in this field are: "D", "E", "I", "N", "U".